CSIMarket
 
United guardian Inc   (NASDAQ: UG)
 
Price: $7.2400 $0.09 1.259%
Day's High: $7.46999979019165 Week Perf: -0.41 %
Day's Low: $ 7.15 30 Day Perf: 2.7 %
Volume (M): 10,089 52 Wk High: $ 8.78
Volume (M$): $ 0 52 Wk Avg: $6.93
Open: $7.15 52 Wk Low: $5.58



 Market Capitalization (Millions $) 33
 Shares Outstanding (Millions) 5
 Employees 25
 Revenues (TTM) (Millions $) 11
 Net Income (TTM) (Millions $) 2
 Cash Flow (TTM) (Millions $) -1
 Capital Exp. (TTM) (Millions $) 0

Business Description


United-Guardian, Inc. is a Delaware corporation that, through its Guardian Laboratories Division ("Guardian"), manufactures and markets cosmetic ingredients, personal care products, pharmaceuticals, medical lubricants, health care products, and specialty industrial products. It also conducts research and product development, primarily related to the development of new and unique cosmetic and personal care products. The Company’s research and development department also modifies, refines, and expands the uses for existing products, with the goal of further developing the market for the Companys products.

Uniteds predecessor, United International Research, Inc. ("UIR"), was founded and incorporated in New York in 1942 by Dr. Alfred R. Globus, Uniteds Chairman and Director of Research until his death on April 9, 2009. On February 10, 1982, a merger took place between UIR and Guardian Chemical Corp. ("GCC"), an affiliate of UIR, whereby GCC was merged into UIR and the name was changed to United-Guardian, Inc., a New York corporation. On September 14, 1987, United-Guardian, Inc. (New York) was merged with and into a newly-formed Delaware corporation by the same name, United-Guardian, Inc., for the purpose of changing the domicile of the Company to Delaware.

The Company manufactures and markets cosmetic ingredients, personal and health care products, medical lubricants, pharmaceuticals, and specialty industrial products. It also conducts research and development, primarily related to the development of new and unique cosmetic and personal care products. The Company focuses on the development of products that fill unmet market needs, have unique properties, and use proprietary technology that it sometimes protects with patents. Many of the Companys products are marketed through collaborative agreements with larger companies. The personal care products manufactured by the Company, including the cosmetic ingredients, are marketed to end users through the Companys worldwide network of marketing partners and distributors, and are currently used by many of the major manufacturers of cosmetic and personal care products. The Company sells product outright to its marketing partners, Ex Works (EXW) the Company’s plant in Hauppauge, New York. Those marketing partners in turn resell those products to their customers, who are typically the manufacturers and marketers of cosmetic and personal care products, and who in turn utilize the Company’s products in their finished products. The products are not sold on a consignment basis, so unless a product is determined to be defective it is not returnable except at the discretion of the Company.

The Company operates in one business segment. The Company’s products are separated into four distinct product categories: personal care products (including cosmetic ingredients), pharmaceuticals, medical products, and industrial products. Each product category is marketed differently.

The Company’s personal care products, including cosmetic ingredients, are marketed globally by six marketing partners, of which Ashland Specialty Ingredients (“ASI”), a business segment of Ashland, Inc., is the largest. The products are sold directly to those marketing partners, which in turn resell those products to its customers for use in the manufacture or compounding of the customers’ personal care and cosmetic products. The Company’s non-pharmaceutical medical products (referred to hereinafter as “medical products”) and the specialty industrial products are sold directly by the Company to the end users or to contract manufacturers utilized by the end users. The Company’s pharmaceutical products are marketed by direct advertising, mailings, and trade exhibitions, and are sold to hospitals and pharmacies primarily through full-line drug wholesalers, which purchase the Company’s products outright for resale to their customers. The Company also sells a small quantity of pharmaceutical products directly to hospitals and pharmacies. The Companys products are sold under trademarks or trade names owned by the Company, some of which are registered with the United States Patent and Trademark Office as well as comparable regulatory agencies in some foreign countries.



   Company Address: 230 Marcus Boulevard Hauppauge 11788 NY
   Company Phone Number: 273-0900   Stock Exchange / Ticker: NASDAQ UG


Customers Net Income grew by UG's Customers Net Profit Margin grew to

13.64 %

7.77 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
IPAR        0.54% 
ALB   -4.62%    
CE        0.49% 
DOW   -2.93%    
EMN   -0.34%    
HUN   -0.21%    
• View Complete Report
   



Dividend

United-Guardian, Inc. Declares 30th Consecutive Dividend, Fueling Investor Confidence Amid Positive Stock Performance

Published Thu, Jan 30 2025 2:00 PM UTC

In a significant announcement that underscores its commitment to shareholder value, United-Guardian, Inc. (NASDAQ:UG) has declared a cash dividend of $0.35 per share, payable on February 18, 2025, for all stockholders of record by the close of business on February 10, 2025. This marks the 30th consecutive year that United-Guardian has distributed dividends, a remarkable achi...

Dividend

United-Guardian Delights Investors with Dividend Increase as Stock Performance Continues to Soar

Published Fri, Jul 12 2024 1:00 PM UTC

United-Guardian Continues Investor-Friendly Approach with Dividend Increase
United-Guardian, Inc. (NASDAQ:UG) has made a strong statement to its investors by announcing a dividend increase of $0.35 per share. This decision was made during the company s recent Board of Directors meeting on July 10, 2024. The dividend will be paid on July 31, 2024, to all stockholders of r...

Management Changes

Denise Costrini Joins United-Guardian Inc. as Marketing Director, Elevating the Company's Performance to Impressive Heights

Published Tue, May 21 2024 1:00 PM UTC



United-Guardian Inc. (NASDAQ:UG), a renowned manufacturer of cosmetic ingredients, pharmaceuticals, medical lubricants, and sexual wellness ingredients, welcomes Denise Costrini as the company s marketing director. With an extensive background spanning over 25 years in the personal care and specialty chemicals industries, Costrini brings a wealth of experience to h...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 13.89
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 3.04
Price to Sales (Expected) -
Price to Book 3.05
PEG (TTM) -

Financial Strength Current
Quick Ratio 5.48
Working Capital Ratio 8.05
Leverage Ratio (MRQ) 0.16
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) 0.52 $
Revenues (TTM) 2.38 $
Cash Flow (TTM) -
Cash 1.75 $
Book Value 2.37 $
Dividend (TTM) 0.85 $

Efficiency Current
Revenue per Employee (TTM) 437,463
Net Income per Employee (TTM) 94,550
Receivable Turnover Ratio (TTM) 6.56
Inventory Turnover Ratio (TTM) 3.97
Asset Turnover Ratio (TTM) 0.85

Profitability Ratios Current
Gross Margin (MRQ) 49.59 %
Operating Margin (MRQ) 22.37 %
Net Margin (MRQ) 28.51 %
Net Cash Flow Margin (MRQ) -17.94 %
Effective Tax Rate (TTM) 20.36 %

Management Effectiveness Current
Return On Assets (TTM) 18.4 %
Return On Investment (TTM) 21.11 %
Return On Equity (TTM) 21.4 %
Dividend Yield 11.74 %
Pay out Ratio (TTM) 163.03 %



United Guardian Inc's Segments
Pharmaceuticals    50.32 % of total Revenue
Cosmetic Ingredients    29.38 % of total Revenue
Medical    20.3 % of total Revenue
UNITED STATES    77.86 % of total Revenue
Non-US    22.14 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.